Ipca Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Ipca Laboratories	Ajanta Pharma	Glaxosmithkline Phar
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	44.0 .	75.0 .	n/a
Number of ANDA's Approved By USFDA	31.0 .	56.0 .	n/a
Domestic Sales Growth - YoY	11.1 %	7.5 %	8.9 %
US DMF Filings	55.0 .	n/a	n/a
R&D as a % of Total Sales	3.12 %	5.0 %	0.07 %
Financials
5 yr Average ROE	11.53 %	21.93 %	45.03 %
5yr average Equity Multiplier	1.57	1.33	1.87
5yr Average Asset Turnover Ratio	0.74	0.86	0.92
5yr Avg Net Profit Margin	10.03 %	19.12 %	27.88 %
Price to Book	5.95	9.52	18.73
P/E	42.05	40.8	40.99
5yr Avg Cash Conversion Cycle	42.73 Days	-104.16 Days	-107.65 Days
Inventory Days	103.2 Days	45.5 Days	47.69 Days
Days Receivable	73.75 Days	49.07 Days	24.45 Days
Days Payable	110.33 Days	180.12 Days	155.09 Days
5yr Average Interest Coverage Ratio	32.12	103.83	556.84
5yr Avg ROCE	15.06 %	28.04 %	48.35 %
5yr Avg Operating Profit Margin	18.38 %	25.85 %	27.99 %
5 yr average Debt to Equity	0.18	0.01	0.0
5yr CAGR Net Profit	5.24 %	8.18 %	-9.37 %
5yr Average Return on Assets	7.5 %	16.5 %	24.4 %
Shareholdings
Promoter Holding	44.72 %	63.48 %	75.0 %
Share Pledged by Promoters	0.0	22.53 %	0.0
Change in Promoter Holding (3 Yrs)	-1.57 %	-2.73 %	0.0
Change in Mutual Fund Holding (3 Yrs)	1.3 %	5.03 %	0.62 %

Business

	Ipca Laboratories	Ajanta Pharma	Glaxosmithkline Phar
Product Wise Break-Up	Product Wise Break-Up Branded Generics 50.39 Formulations 33.08 Active Pharmaceutical Ingredient (API) 16.53 Pharmaceutical products 0 Vaccines 0 Pharmaceuticals 0	Product Wise Break-Up Branded Generics 0 Vaccines 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceuticals 0 Formulations 0 Pharmaceutical 100.0	Product Wise Break-Up Branded Generics 0 Vaccines 24.0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 76.0 Formulations 0 Pharmaceutical products 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 53.0 Cardiac Science 17.0 Dermatology 6.0 Urology 5.0 Anti-bacterial 5.0 Cough and colds 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 1.0	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 0 Gastro Intestinal 0 Vitamins/Minerals/Nutrients 0 Cardiac Science 0 Cough and colds 0 Anti-bacterial 0 Neutraceuticals 0 Vaccines 0 Anti-Infectives 0 Dermatology 22.0 Pain/Analgesics 0 Urology 0 0 Hormones 0 Anti Malarials 0 Respiratory 0 Pain 10.0 Others 68.0	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 0 Gastro Intestinal 0 Vitamins / Minerals / Nutrients 6.47 Cardiac Science 0 Cough and colds 0 Anti-bacterial 0 Neutraceuticals 0 Vaccines 12.64 Anti-Infective 22.25 Dermatology 30.55 Pain Management 11.96 Urology 0 0 Hormones 8.91 Anti Malarials 0 Respiratory 3.95 Pain 0 Others 3.27
Location Wise Break-Up	Location Wise Break-Up India 44.73 USA 21.58 Europe 15.68 Africa 6.72 Asia Pacific 5.18 Australia 3.2 CIS 2.91 Asia 0 Rest of the World 0	Location Wise Break-Up Asia Pacific 19.39 Australia 0 Rest of the World 0 CIS 0 Africa 16.28 Asia Pacific 0 India 28.59 Europe 0 USA 35.74	Location Wise Break-Up Asia 0 Australia 0 Rest of the World 1.36 CIS 0 Africa 0 Asia Pacific 0 India 98.64 Europe 0 USA 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	-

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE